These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20107195)

  • 21. Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.
    Hirschler V; Meroño T; Maccallini G; Gomez Rosso L; Aranda C; Brites F
    Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):78-83. PubMed ID: 21476960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
    ; Thompson A; Gao P; Orfei L; Watson S; Di Angelantonio E; Kaptoge S; Ballantyne C; Cannon CP; Criqui M; Cushman M; Hofman A; Packard C; Thompson SG; Collins R; Danesh J
    Lancet; 2010 May; 375(9725):1536-44. PubMed ID: 20435228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.
    Kinney GL; Snell-Bergeon JK; Maahs DM; Eckel RH; Ehrlich J; Rewers M; Hokanson JE
    Diabetes Technol Ther; 2011 Mar; 13(3):381-7. PubMed ID: 21291330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.
    Gong HP; Du YM; Zhong LN; Dong ZQ; Wang X; Mao YJ; Lu QH
    Lipids Health Dis; 2011 Jan; 10():13. PubMed ID: 21247435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of lipoprotein-associated phospholipase A₂ with characteristics of vulnerable coronary atherosclerotic plaques.
    Liu YS; Hu XB; Li HZ; Jiang WD; Wang X; Lin H; Qin AQ; Wang YM; Zhao T; Dong ZQ; Zhang M; Lu QH
    Yonsei Med J; 2011 Nov; 52(6):914-22. PubMed ID: 22028154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
    Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
    Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease.
    Massot A; Pelegri D; Penalba A; Arenillas J; Boada C; Giralt D; Ribó M; Molina CA; Rosell A; Alvarez-Sabín J; Chacón P; Rovira A; Delgado P; Montaner J
    Atherosclerosis; 2011 Sep; 218(1):181-7. PubMed ID: 21620406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes.
    Hatoum IJ; Hu FB; Nelson JJ; Rimm EB
    Diabetes; 2010 May; 59(5):1239-43. PubMed ID: 20185811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
    Onat A; Hergenç G; Can G; Uğur M; Nartop F
    Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].
    Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
    Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.
    Constantinides A; Kappelle PJ; Lambert G; Dullaart RP
    Arch Med Res; 2012 Jan; 43(1):11-4. PubMed ID: 22300679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort.
    Persson M; Nilsson JA; Nelson JJ; Hedblad B; Berglund G
    Atherosclerosis; 2007 Feb; 190(2):388-96. PubMed ID: 16530769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
    Qiao Z; Ren J; Chen H
    J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
    Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
    J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diurnal variation in lipoprotein-associated phospholipase A(2) (Lp-PLA(2)).
    Kaminsky LA; Ozemek C
    Clin Biochem; 2012 Jun; 45(9):700-2. PubMed ID: 22465237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
    Epps KC; Wilensky RL
    J Intern Med; 2011 Jan; 269(1):94-106. PubMed ID: 21054587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
    Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
    Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.